# Nalu Bio: Research, San Francisco, United States

> Nalu Bio: Nalu Bio is a biotechnology company based in San Francisco that focuses on developing cannabinoid-inspired therapeutics.

Source: https://millionrounds.com/startup/nalu-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Nalu Bio

Nalu Bio is a biotechnology company based in San Francisco that focuses on developing cannabinoid-inspired therapeutics.

Funding reported Last round: Series A

Research San Francisco, United States

Company summary

- **Founded:** 2019 7 years old
- **Team:** 14 11 to 50 people
- **Funding reported:** $12M in dollars
- **Last round:** Series A Feb 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Nalu Bio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Nalu Bio

Nalu Bio is a biotechnology company based in San Francisco that focuses on developing cannabinoid-inspired therapeutics.

The company aims to address the historical omission of the endocannabinoid system from mainstream medicine by creating non-addictive alternatives to opioids for pain management. Nalu Bio utilizes a proprietary, AI-powered platform that combines machine learning and biological modeling to accelerate drug development while ensuring safety and efficacy. The product pipeline includes prescription therapeutics and vitamins, minerals, and supplements (VMS) targeting various health conditions such as pain management, weight management, and immune disorders. Key offerings include synthetic cannabidiol (CBD) for pain and opioid addiction, THCV-based compounds for weight management, and novel chemical entities for conditions like endometriosis. Nalu Bio's innovative approach emphasizes organic synthesis to eliminate contamination risks, positioning its products for significant impact in both pharmaceutical and retail health markets.

## What company datasets say Nalu Bio raised

Funding, as reported

Reported in all **$12M** in dollars

Rounds **4**

Last round **Series A**

Last round size **$12M**

Last round date **Feb 2023**

Investors listed **11**

SEC Form D **$4.8M sold, 1 filing, last Mar 2023**

## Founders and team

From Nalu Bio's own website and the SEC filings it signed: 3 founders, 1 on the team.

**Caitlyn Krebs** Co-founder + CEO *Named on its 2023 Form D*

**Phyllis E. Whiteley** Co-founder + Board Member *Named on its 2023 Form D*

**Randall S. Ussery** Co-founder + Board Member *Named on its 2023 Form D*

- **Bill Kehoe** Chief Financial Officer

On the board, as filed i *Howard E. Goodwin*

## On 3 portfolio pages

Investors who name them

- [Next Act Fund](https://millionrounds.com/fund/next-act-fund-llc)
- [Portfolia](https://millionrounds.com/fund/portfolia)
- [Brown Angel Group](https://millionrounds.com/fund/brown-angel-group)

Each firm lists Nalu Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

stress health care bioavailability biotechnology research pharmaceutical pipeline manufacturing cannabinoid receptor modulation non-addictive therapeutics regulatory pathway receptor-specific compounds receptor modulation cannabinoid research vms precision ecs medicines information technology & services cpg

Built with from their website

Google Workspace CloudFlare Viewport Meta Varnish webpack Google Meet Priority Hints React Sirvoy Wix eCommerce

+8 more

MySQL WebsiteBuilder Mobile Friendly Lodash Open Graph RSS Wordpress.com HTTP/3

- **Sector:** Research
- **Industry code:** NAICS 541714, 325411, SIC 2834, 8731
- **Region:** California
- **Revenue:** $2.8M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/nalu-bio)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Nalu Bio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)